Hereditary Pancreatitis
8
5
6
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (8)
A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
French National Cohort of Patients With PRSS1 Mutations
Pancreatic Cancer Early Detection Program
Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer.
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Registry of Subjects at Risk of Pancreatic Cancer
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas